Here's the live share price of Granules India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Granules India has gained 9.60% CAGR. Over the past year, the corresponding return has been 2.54%.
Granules India’s current P/E of 24.75x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Granules India | -1.40 | -5.88 | 0.10 | 20.88 | 2.54 | 24.88 | 9.60 |
| Sun Pharmaceutical Industries | 0.19 | -1.84 | -2.18 | 3.57 | -2.78 | 18.71 | 22.04 |
| Divi's Laboratories | 2.58 | -3.94 | -6.21 | 1.26 | 2.84 | 30.60 | 10.74 |
| Torrent Pharmaceuticals | 3.41 | 3.41 | 6.50 | 12.61 | 32.50 | 39.05 | 25.61 |
| Cipla | 0.07 | -8.01 | -12.72 | -14.74 | -9.54 | 9.23 | 9.54 |
| Dr. Reddy's Laboratories | 2.21 | 6.57 | 2.76 | 1.28 | 3.70 | 11.94 | 6.13 |
| Lupin | 1.42 | 1.03 | 7.13 | 10.56 | 6.98 | 48.24 | 15.75 |
| Zydus Lifesciences | 1.91 | 0.51 | -4.17 | -8.52 | -3.99 | 24.30 | 14.15 |
| Mankind Pharma | 0.05 | -6.89 | -8.66 | -16.42 | -17.51 | 13.11 | 7.67 |
| Aurobindo Pharma | -3.00 | -0.99 | -4.42 | 7.27 | -2.08 | 34.73 | 4.39 |
| Alkem Laboratories | -5.01 | -7.85 | -5.63 | 0.17 | 14.35 | 18.24 | 13.35 |
| Biocon | 3.45 | 0.13 | -9.41 | 4.89 | 5.12 | 16.70 | -1.51 |
| Abbott India | -3.12 | -5.59 | -10.27 | -19.61 | -6.53 | 9.42 | 12.92 |
| Glenmark Pharmaceuticals | 3.19 | -0.65 | 6.37 | -1.76 | 41.57 | 67.75 | 32.40 |
| Laurus Labs | 6.46 | -4.28 | 1.50 | 17.20 | 68.43 | 44.88 | 22.37 |
| GlaxoSmithKline Pharmaceuticals | 4.19 | 9.29 | 3.87 | -6.62 | 29.78 | 27.19 | 12.57 |
| Anthem Biosciences | 5.45 | 9.58 | -1.34 | -8.72 | -5.68 | -1.93 | -1.16 |
| Ipca Laboratories | 3.39 | -2.27 | 13.03 | 7.95 | -1.28 | 19.79 | 9.20 |
| Ajanta Pharma | 2.13 | 6.67 | 14.33 | 9.17 | 16.83 | 32.97 | 19.32 |
| J B Chemicals & Pharmaceuticals | 2.47 | 1.54 | 4.24 | 10.53 | 12.50 | 24.86 | 25.01 |
Over the last one year, Granules India has gained 2.54% compared to peers like Sun Pharmaceutical Industries (-2.78%), Divi's Laboratories (2.84%), Torrent Pharmaceuticals (32.50%). From a 5 year perspective, Granules India has underperformed peers relative to Sun Pharmaceutical Industries (22.04%) and Divi's Laboratories (10.74%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 574.38 | 575.2 |
| 10 | 570.14 | 573.18 |
| 20 | 570 | 574.52 |
| 50 | 581.11 | 574.41 |
| 100 | 566.83 | 562.6 |
| 200 | 528.95 | 545.63 |
In the latest quarter, Granules India remained same as its previous close in promoter holding, while DII stake decreased to 17.47%, FII holding fell to 13.55%, and public shareholding moved up to 30.15% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 24,41,258 | 2.28 | 146.11 | |
| 22,09,668 | 0.92 | 122.88 | |
| 15,82,000 | 3.95 | 94.68 | |
| 11,06,670 | 1.34 | 66.23 | |
| 11,00,000 | 1.58 | 65.84 | |
| 10,38,748 | 0.93 | 62.17 | |
| 10,00,767 | 1.09 | 59.9 | |
| 5,33,136 | 1.12 | 31.91 | |
| 3,35,000 | 0.55 | 18.63 | |
| 2,91,611 | 0.06 | 17.45 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Feb 06, 2026, 8:14 PM IST | Granules India - Updates |
| Jan 28, 2026, 8:55 PM IST | Granules India - Transcript For Earnings Conference Call For Q3 Of FY26 |
| Jan 23, 2026, 10:43 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Jan 23, 2026, 10:39 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Jan 23, 2026, 10:31 PM IST | Granules India L - Board Meeting Outcome for Outcome Of The Board Meeting |
Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1991PLC012471 and registration number is 012471. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 3030.16 Cr. and Equity Capital is Rs. 24.25 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Granules India is ₹556.40 as on Feb 13, 2026.
The Granules India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Granules India is ₹13,502.09 Cr as on Feb 13, 2026.
Today’s highest and lowest price of Granules India are ₹570.50 and ₹555.50.
The 52-week high/low is the highest and lowest price at which Granules India stock has traded in the past 52-week or nearly a year. The 52-week high of Granules India is ₹627.45 and 52-week low of Granules India is ₹412.05 as on Feb 13, 2026.
The Granules India has shown returns of -2.29% over the past day, -5.88% for the past month, 0.1% over 3 months, 2.54% over 1 year, 24.88% across 3 years, and 9.6% over 5 years.
P/E ratio of and PB ratio of Granules India are 24.75 and 3.39 on Feb 13, 2026. While the company gives a dividend yield of 0.27 per annum.